Skip to main content
Home
Loading...
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube

Menu top

  • Assistance

User account menu

  • Log in
Home

Main navigation

  • Home
  • Programme
Menu Login
Close

Main navigation mobile

  • Home
  • Programme

Menu top

  • Assistance
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube
Filters
Filters Close
Poster topics
  • Asthma (14)
  • Basic immunology (1)
  • Biologicals (18)
  • Biomarkers (7)
  • x Dermatology (4)
  • Drug allergy (2)
  • ENT (3)
  • Environmental allergy and climate change (1)
  • Epidemiology (3)
  • Genomics and proteomics (1)
  • Immune deficiencies and autoimmunity (1)
  • Infections (1)
  • Occupational allergy (1)
  • Ocular allergy (1)
  • One Health (1)
  • Pediatrics (1)
Poster available until
Poster categories
  • Thematic Poster Session (4)
keywords
Session Reference
  • x L-TPS02 (3)
  • L-TPS07 (7)
  • L-TPS08 (1)
  • L-TPS09 (2)
  • L-TPS15 (4)
  • L-TPS20 (12)
  • L-TPS21 (1)
  • TPS02 (2)
  • TPS15 (10)
  • TPS17 (1)
  • TPS21 (1)
  • TPS28 (1)
  • TPS38 (13)
  • TPS39 (13)
  • TPS52 (11)
  • TPS53 (6)
  • TPS57 (1)
  • TPS64 (11)
  • TPS66 (1)
  • x TPS67 (1)
  • TPS68 (3)
4 results
Thumbnail

D1.123 - Inhibition of the Interleukin Cytokines using novel Peptide Inhibitors for Allergy and Asthma Treatment

Thumbnail

D1.128 - Dupilumab in a Child with Severe Allergic Asthma, Atopic Dermatitis, Vernal Keratoconjunctivitis, and Partial IgA Deficiency

Thumbnail

D1.129 - Bispecific Antibody Targeting IL-33 and TSLP for Treating Asthma and COPD

Thumbnail

D3.366 - Exploring potential predictive factors for time to response to Omalizumab treatment in a Romanian subset of patients with Chronic Spontaneous Urticaria

Download the app
The congress at your fingertips

Available on

App Store Google Play
QR Code Download
Mobile App Schedule page
Mobile App Home page
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube
© 2025 EAACI
Made with   by CYIM